Login / Signup
Does anti-VEGF bevacizumab improve survival in experimental sepsis?
Emmanuel Besnier
Ebba Brakenhielm
Vincent Richard
Fabienne Tamion
Published in:
Critical care (London, England) (2017)
Keyphrases
</>
vascular endothelial growth factor
septic shock
acute kidney injury
intensive care unit
endothelial cells
metastatic colorectal cancer
free survival